
Advertise on podcast: Psychopharmacology and Psychiatry Updates
Rating
4.7from
This podcast has
100 episodes
Language
EnglishPublisher
Psychopharmacology InstituteExplicit
No
Date created
2018/08/10
Latest episode
2026/11/12
Average duration
13 min.
Release period
6 days
Description
Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.
Unlock Psychopharmacology and Psychiatry Updates podcast Email contact info,
Listeners & Audience details
Email contact information
Direct podcast contact details

Listeners
Audience numbers & engagement insights

Audience details
Podcast Insights

Podcast episodes
Check latest episodes from Psychopharmacology and Psychiatry Updates podcast
Liver Disease: Buprenorphine, Methadone, and Smoking Cessation Agents
2026/11/12
Faculty: Kevin A. Sevarino, M.D.C.M., Ph.D.
Host: Flavio Guzmán, M.D.
Learn more about our memberships here Earn 1.25 CME: Addiction Psychopharmacology in Patients with Medical Comorbidities Liver Disease: Buprenorphine, Methadone, and Smoking Cessation Agents
Catatonia: Should Antipsychotics Always Be Avoided?
2026/11/08
Faculty: Scott R. Beach, M.D.
Host: Flavio Guzmán, M.D.
Learn more about our membership here Earn 0.75 CMEs: Quick Take Vol. 88 Catatonia: Should Antipsychotics Always Be Avoided?
Prazosin for PTSD Nightmares
2026/11/02
In this episode, we explore prazosin for PTSD-related nightmares with Dr. David Osser. He explains why prazosin stands out among alpha-1 blockers, which patients are most likely to respond, and why so many trials failed from underdosing, including how titration differs for men and women.
Faculty: David Osser, M.D.
Host: Flavio Guzmán, M.D.
Learn more about our memberships here Earn 1.5 CME: PTSD Psychopharmacology Algorithm Prazosin for PTSD Nightmares: Dosing Protocols for Men and Women
First-Episode Psychosis in Women
2026/10/28
Faculty: Amanda Koire, M.D., Ph.D.
Host: Flavio Guzmán, M.D.
Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 87 First-Episode Psychosis in Women: Which Antipsychotic Is the Preferred Choice?
Second-Generation Antipsychotics for OCD Augmentation
2026/10/23
Faculty: Robert Hudak, M.D.
Host: Flavio Guzmán, M.D.
Learn more about our memberships here Earn 1.25 CME: Treatment-Resistant OCD: From SSRIs to Augmentation Second-Generation Antipsychotics for OCD Augmentation: Third-Line Agents
Are Z-Drugs Safe in the First Trimester of Pregnancy?
2026/10/18
In this episode, we review a JAMA Psychiatry study of over 4 million pregnancies examining first-trimester Z-drug exposure and congenital malformations. Dr. Amanda Koire explains why overall risk wasn't increased, what the neural tube defect signal means, and how to evaluate insomnia before prescribing.
Faculty: Amanda Koire, M.D., Ph.D.
Host: Flavio Guzmán, M.D.
Learn more about our membership here Earn 0.75 CMEs: Quick Take Vol. 86 Are Z-Drugs Safe in the First Trimester of Pregnancy?
Glutamatergic Augmentation in OCD
2026/10/13
Faculty: Robert Hudak, M.D.
Host: Flavio Guzmán, M.D.
Learn more about our memberships here Earn 1.25 CME: Treatment-Resistant OCD: From SSRIs to Augmentation Glutamatergic Augmentation in OCD: Memantine, Riluzole, Lamotrigine and Other Agents
Schizophrenia: Which of Seven Antipsychotics Wins?
2026/10/09
Faculty: Oliver Freudenreich, M.D.
Host: Flavio Guzmán, M.D.
Learn more about our memberships here Earn 0.75 CMEs: Quick Take Vol. 85 Schizophrenia: Which of Seven Antipsychotics Wins on Acute Efficacy and Safety?
SSRI Dosing for OCD: Beyond FDA Guidelines
2026/10/03
Faculty: Robert Hudak, M.D.
Host: Flavio Guzmán, M.D.
Learn more about our memberships here Earn 1.25 CME: SSRI Dosing for OCD: Beyond FDA Guidelines Treatment-Resistant OCD: From SSRIs to Augmentation
Trazodone for Insomnia and Comorbid Depression
2026/09/28
In this episode, we explore a new meta-analysis reconciling trazodone's real-world reputation with cautious sleep medicine guidelines, examining its effects on sleep architecture and depressive symptoms in patients with comorbid insomnia and depression, alongside its notable side effect profile. Can a decades-old antidepressant be the missing link for restorative sleep?
Faculty: Paul Zarkowski, M.D.
Host: Flavio Guzmán, M.D.
Learn more about our memberships here Earn 0.5 CMEs: Quick Take Vol. 85 Trazodone for Insomnia and Comorbid Depression: Are the AASM Guidelines Relevant?
Antipsychotics, Prolactin, and Sexual Side Effects
2026/09/23
In this episode, we explore why antipsychotics cause hyperprolactinemia and sexual side effects, a leading reason patients quietly stop treatment. Dr. Oliver Freudenreich breaks down which medications carry the highest risk, the long-term health implications, and practical strategies for monitoring, switching, or augmenting therapy.
Faculty: Oliver Freudenreich, M.D., F.A.C.L.P.
Host: Richard Seeber, M.D.
Learn more about our memberships here Earn 1.25 CME: Managing Side Effects of Antipsychotics: What Every Psychiatrist Should Know Managing Hyperprolactinemia and Sexual Side Effects from Antipsychotic Use
EMERGENT-5: Cobenfy and Treatment Durability
2026/09/18
In this episode, we sit down with Dr. Oliver Freudenreich to unpack EMERGENT-5, the year-long trial tracking Cobenfy's real-world durability and safety in schizophrenia. We explore whether early symptom gains hold up over time, what side effects persist, and why blood pressure monitoring now deserves a permanent spot on your checklist.
Faculty: Oliver Freudenreich, M.D., F.A.C.L.P.
Host: Richard Seeber, M.D.
Learn more about our membership here Earn 0.5 CME: Quick Take Vol. 85 Xanomeline-Trospium Long-Term: Does Efficacy and Safety Hold Up After One Year?
Antipsychotics and Weight Gain
2026/09/13
In this episode, we sit down with Dr. Oliver Freudenreich to unpack antipsychotic-induced weight gain — why it happens, which medications carry the highest risk, and how to build a proactive ABC strategy using switching, metformin, and emerging GLP-1 agonists to protect your patients' metabolic health.
Faculty: Oliver Freudenreich, M.D., F.A.C.L.P.
Host: Richard Seeber, M.D.
Learn more about our memberships here Earn 1.25 CME: Managing Side Effects of Antipsychotics: What Every Psychiatrist Should Know Antipsychotic-Induced Weight Gain: Prevention and Management
EPA vs. DHA: Fish Oil and Treatment-Resistant Depression
2026/09/08
In this episode, we explore whether EPA, a specific omega-3 fatty acid, can help patients with treatment-resistant depression. Dr. Derick Vergne breaks down the clinical evidence, dosing, and the anti-inflammatory mechanisms that may explain why EPA outperforms DHA in easing stubborn depressive symptoms.
Faculty: Derick E. Vergne, M.D.
Host: Richard Seeber, M.D.
Learn more about our memberships here Earn 0.75 CMEs: Quick Take Vol. 84 Eicosapentaenoic Acid: Effective as Adjunctive for TRD?
AUD Medications and Hepatic Safety
2026/09/03
In this episode, we explore how liver status shapes medication choice for alcohol use disorder. Dr. Kevin Sevarino breaks down a practical algorithm for selecting between naltrexone, acamprosate, disulfiram, and other options, tailored to hepatic function, from early liver disease through decompensated cirrhosis.
Faculty: Kevin A. Sevarino, M.D.C.M., Ph.D.
Host: Richard Seeber, M.D.
Learn more about our memberships here Earn 1.25 CME: Pharmacotherapy of Alcohol Use Disorder Alcohol Use Disorder Algorithm: Medication Selection Based on Liver Status
Podcast reviews
Read Psychopharmacology and Psychiatry Updates podcast reviews
GIProphet 2026/03/19
Solid, straightforward psychopharmacology
So good. I love that the episodes are full of good useful tips to prescribe and manage psych meds.
Tavar1234 2022/11/21
Smita Varshney MD
Love to listen to daily pearls!
DEG1966 2022/05/17
DocGermosen
Is a wonderful way to end the day by listening to current and relevant treatment information, base on different reviews of RCT’s.
Joy from New York 2022/01/07
A Mental Health Pharmacist’s Take
I really enjoy this podcast. As a Pharmacist Practitioner, I really enjoy having this available and listen to the podcast regularly. I also tend to se...
docbunz 2021/12/03
Wonderful tool as a clinician!
Each day on my drive to work I listen to this podcast and I learn a lot from the expertise of the speakers. The episodes are current, relevant, short,...
Jayne Kavi 2021/08/23
Helpful, Clear and Concise
I enjoy learning through Psychopharmacology Institute ‘s programs!
Laura Lilli 2021/07/12
Super helpful and a quick listen!
As a PMHNP student, this podcast has been so helpful for learning and reinforcing psychopharmacology! I appreciate that each episode is a quick listen...
andysphere 2021/05/28
Mostly Fluff & Filler
Podcast has very little substance. It’s mostly fluff and filler. Hosts and guests are poor speakers, very boring and often quite hard to understand. T...
beehive2016 2018/11/19
Great for clinicians!
Awesome listen on the way to work, gets the mind going in short segments and adds new ideas while I’m actively seeing patients.
Podcast sponsorship advertising
Start advertising on Psychopharmacology and Psychiatry Updates relevant audience podcasts
You may also like to advertise on these Podcasts

4.8259411508
Relatable with Allie Beth Stuckey
Blaze Podcast Network

4.831561382
The Late-Round Fantasy Football Podcast
iHeartPodcasts

4.6137891999
The Rubin Report
Dave Rubin

4.732772000
The President's Daily Brief
The First TV

4.672712000
Timcast News
Timcast Media

4.861551136
The David Pakman Show
David Pakman

4.917111576
DarrenDaily On-Demand
Darren Hardy LLC

4.736061325
The Bonfire with Big Jay Oakerson and Robert Kelly
SiriusXM

4.922782003
First15 Devotional
First15

4.818412000
The Cabral Concept
Dr. Stephen Cabral